Latest News
Conference Coverage
Consider varying generational needs, preferences in the workplace and with patients
NASHVILLE, TENN. – Generational differences have important implications for communication, education, and more –...
FDA/CDC
Insomnia meds get boxed warning from FDA
Although complex sleep behaviors, such as sleep walking, associated with these medications are rare, the consequences can be deadly.
FDA/CDC
Ruzurgi approved for Lambert-Eaton myasthenic syndrome in patients under age 17
The approval is the first for a LEMS treatment specifically for pediatric patients.
Conference Coverage
The art of selecting an MS therapy
DALLAS – Clinical and imaging findings may indicate disease phase, severity, and prognosis, which can inform the treatment choice.
Conference Coverage
Patients describe significant impact of epilepsy on their lives
PHILADELPHIA – Symptoms reported most commonly were twitching/tremors, confusion, difficulty talking, impaired/loss of consciousness, stiffening,...
Conference Coverage
Physical activity slows cognitive decline in patients with Parkinson’s disease
PHILADELPHIA - Higher levels of activity throughout the course of the disease are associated with better cognitive performance.
Conference Coverage
Cannabidiol reduces seizures in Dravet syndrome
PHILADELPHIA – Two dosages of the CBD treatment appear to have similar efficacy, but the lower dose may be more...
Conference Coverage
Researchers examine vitamin D, skin pigmentation, and outcomes of pediatric MS
PHILADELPHIA – The association between vitamin D insufficiency and MS outcome in children appears to relate partly...
Conference Coverage
Guideline issued for treating Tourette syndrome and chronic tics
PHILADELPHIA – Neurologists should consider prescribing Comprehensive Behavioral Intervention for Tics as a first-line treatment, relative to...
Latest News
Criterion based on the central vein sign distinguishes between MS and mimics
PHILADELPHIA – Applying the criterion of three lesions with the central vein sign is feasible in clinical practice...
Conference Coverage
Laquinimod may not improve motor function in Huntington’s disease
PHILADELPHIA – The drug raises no new safety concerns in patients with Huntington’s disease, compared with previous...